跳至主要内容
临床试验/ITMCTR1900002787
ITMCTR1900002787招募中1 期

Optimization of clinical regimen of traditional Chinese medicine therapy for Parkinson's disease based on AMPK/SIRT3/GSK3ß /LC3 signaling pathway

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • Early stage:
  • (1) qualified for TCM diagnostic criteria of fibrillation syndrome;
  • (2) meet the western diagnostic criteria for Parkinson's disease;
  • (3) aged >= 50 years, <= 75 years;
  • (4) the improved Hoehn&Yahr is graded from grade 1 to grade 1.5;
  • (5) TCM syndrome differentiation: Yin deficiency of liver and kidney.
  • Middle stage:
  • (1) qualified for TCM diagnostic criteria of fibrillation syndrome;
  • (2) meet the western diagnostic criteria for Parkinson's disease;
  • (3) aged >= 50 years, <= 75 years;
  • (4) the improved Hoehn & Yahr is graded at level 2 ~ 3;
  • (5) TCM syndrome differentiation: Yin deficiency of liver and kidney.

排除标准

  • 1. Those who have been treated with levodopa or traditional Chinese medicine for tonifying liver and kidney without drug elution;
  • 2. Have serious heart, liver, kidney disease or multiple organ failure, mental illness;
  • 3. A history of drug or alcohol abuse;
  • 4. Pregnant and lactating women;
  • 5. Patients in other studies.

研究者

发起方
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

相似试验